The Team

Nathan Revel
Nathan Revel
CEO

CEO. Biotech finance leader with 15+ years at Gilead Sciences, PwC, and BofA, plus operating finance roles at clinical-stage biotechs from IND through commercial launch. Built Exigyn because every FP&A tool he used was designed for SaaS — biotech deserved its own. Bachelors Degree from USF. MBA from University of Illinois Urbana Champaign.

Steve Ochoa
Steve Ochoa
Chief AI Scientist

Chief AI Scientist. Software engineer with a career shipping production systems at Quicken, Magnite, and MetricWorks. Leads Exigyn's agentic AI layer — the Excel and PowerPoint connectors that pull live planning data into the tools biotech finance teams already use. Bachelors in Computer Science from Oregon State.

Angus Hsu
Angus Hsu
Business Development Lead

Business Development Lead. Started in corporate finance at Wells Fargo before pivoting into healthcare, working across commercial and R&D finance in pharma and medical devices. Passionate about using the latest financial planning toolset to automate back-office modeling and deck creation — so finance teams can focus on the most strategic decisions possible. UC Berkeley, B.A. in Economics. MBA from UCLA

Nathan Revel
Nathan Revel
CEO

CEO. Biotech finance leader with 15+ years at Gilead Sciences, PwC, and BofA, plus operating finance roles at clinical-stage biotechs from IND through commercial launch. Built Exigyn because every FP&A tool he used was designed for SaaS — biotech deserved its own. Bachelors Degree from USF. MBA from University of Illinois Urbana Champaign.

Steve Ochoa
Steve Ochoa
Chief AI Scientist

Chief AI Scientist. Software engineer with a career shipping production systems at Quicken, Magnite, and MetricWorks. Leads Exigyn's agentic AI layer — the Excel and PowerPoint connectors that pull live planning data into the tools biotech finance teams already use. Bachelors in Computer Science from Oregon State.

Angus Hsu
Angus Hsu
Business Development Lead

Business Development Lead. Started in corporate finance at Wells Fargo before pivoting into healthcare, working across commercial and R&D finance in pharma and medical devices. Passionate about using the latest financial planning toolset to automate back-office modeling and deck creation — so finance teams can focus on the most strategic decisions possible. UC Berkeley, B.A. in Economics. MBA from UCLA